logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Platelet Aggregation Inhibitor class drugs

    FiltersReset Filters
    7 results

    • aspirin and extended-release dipyridamole

      (Aspirin and Extended-Release Dipyridamole)
      AvKARE
      Usage: Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients with a history of transient ischemia of the brain or completed ischemic stroke caused by thrombosis.

    • asprin and extended-release dipyridamole

      (ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Aspirin and extended-release dipyridamole capsules are indicated for reducing the risk of stroke in patients with a history of transient ischemia of the brain or completed ischemic stroke due to thrombosis.

    • butalbital, aspirin, and caffeine

      (butalbital, aspirin, and caffeine)
      Chartwell RX, LLC
      Usage: Butalbital, aspirin, and caffeine capsules are indicated for relieving tension or muscle contraction headache symptoms. There is insufficient evidence for their efficacy in multiple recurrent headaches. Caution is advised due to the potential for habit formation and abuse associated with butalbital.

    • butalbital, aspirin, caffeine and codeine phosphate

      (BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE)
      Amneal Pharmaceuticals of New York, LLC
      Usage: BUTALBITAL, ASPIRIN, CAFFEINE, and CODEINE PHOSPHATE are indicated for managing tension headaches when non-opioid analgesics are ineffective. Due to addiction risks, it is recommended for patients who cannot tolerate or do not achieve adequate relief from non-opioid treatments and should not be used long-term.

    • eptifibatide

      (Eptifibatide)
      Hainan Shuangcheng Pharmaceuticals Co., Ltd.
      Usage: Eptifibatide injection is indicated to reduce the risk of death or new myocardial infarction in patients with acute coronary syndrome (ACS) and to decrease the rate of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI), including those receiving intracoronary stenting.

    • norgesic forte

      (Orphenadrine Citrate, Aspirin and Caffeine)
      Poly Pharmaceuticals, Inc.
      Usage: Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain from acute musculoskeletal disorders and as an adjunct to rest and physical therapy for discomfort associated with these conditions. The action of orphenadrine may relate to its analgesic properties.

    • oxycodone and aspirin

      (Oxycodone and Aspirin)
      Epic Pharma, LLC
      Usage: Oxycodone and aspirin tablets are indicated for managing severe pain that requires an opioid analgesic when alternative treatments are ineffective or intolerable. Due to addiction and misuse risks, they should be used only when other options fail.